Clinical Context

Chronic fatigue syndrome (CFS/ME) substantially limits a person's capacity to perform daily activities. Evidence-based first-line management directly targets symptom severity and activity performance through a structured, personalised approach to pacing.

Treatment Approach — Partial Overview

The first-line strategy is built around adaptive pacing therapy (APT): a personalised programme that sets reasonable daily activity targets and deliberately balances activity with rest to avoid aggravating symptoms.

The full structured regimen — including the complete pacing algorithm, individualised escalation steps, and activity titration framework — is available in the protocol below.

Treatment Goals

Primary targets are improvement in symptom severity and enhanced performance of daily activities, evaluated at 3 weeks from initiation.

References

DOI: 10.1111/bph.13702

Patients receiving APT are instructed to set themselves reasonable targets for their daily activity and exercise and to avoid possible over-exertion (and aggravation of symptoms) by striking a balance between activity and rest.
APT patients functioning within their individual limits then gradually raise their activity and exercise levels (i.e. GET).
Pacing was also the most effective, safe, acceptable and preferred form of activity management for CFS/ME and should therefore be a key component of any illness management programme.
The results suggested that 3 weeks of pacing self-management improves symptom severity and performance of daily activities, but a larger RCT is required to confirm these preliminary observations.

View source ↗

What Is the First-Line Treatment of Chronic Fatigue Syndrome?

References